A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
Substituted tricyclics
申请人:Eli Lilly and Company
公开号:US06448284B1
公开(公告)日:2002-09-10
A class of tricycles is disclosed together with the use of such for inhibiting Spla2 mediated release of fatty acids for the treatment of conditions such as septic shock.